Clarity Pharmaceuticals (CLRPF) Q1 2026 Earnings

Feb 25Confirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.1
-0.08
-0.06
-0.03

Details

Expected EPS
-0.05511485
Actual EPS
-0.10208925
Surprise EPS
-0.05
Surprise Percent
-85.23%

Description

⁨Clarity Pharmaceuticals⁩ (⁦CLRPF⁩) has reported earnings of ⁦-0.10208925⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts